We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
-14.25%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
-$78.4B
Cap. Flow
+$5.92B
Cap. Flow %
1.35%
Top 10 Hldgs %
19.19%
Holding
4,820
New
167
Increased
1,786
Reduced
2,376
Closed
241

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$305M
2
TSLA icon
Tesla
TSLA
+$304M
3
XOM icon
ExxonMobil
XOM
+$277M
4
WBD icon
Warner Bros
WBD
+$263M
5
LIN icon
Linde
LIN
+$237M

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 14.61%
3 Financials 11.99%
4 Consumer Discretionary 9.25%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGL
4526
DELISTED
Vigil Neuroscience
VIGL
-13,341
Closed -$94K
VIOV icon
4527
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.91B
-2,464
Closed -$218K
VMD icon
4528
Viemed Healthcare
VMD
$360M
-116,431
Closed -$580K
VOR icon
4529
Vor Biopharma
VOR
$1.36B
-2,769
Closed -$335K
VTAK icon
4530
Catheter Precision
VTAK
$1.03M
-3
Closed -$11K
XCUR icon
4531
Exicure
XCUR
$8.29M
-310
Closed -$9K
XGN icon
4532
Exagen
XGN
$157M
-25,917
Closed -$208K
XLO icon
4533
Xilio Therapeutics
XLO
$59.2M
-1,502
Closed -$149K
ZVIA icon
4534
Zevia
ZVIA
$105M
-31,328
Closed -$144K
LENZ
4535
LENZ Therapeutics
LENZ
$150M
-10,943
Closed -$391K
BTX
4536
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
-15,114
Closed -$173K
NBIS
4537
Nebius Group N.V.
NBIS
$69.2B
-806,622
Closed -$15.3M
CLYM
4538
Climb Bio
CLYM
$841M
-13,893
Closed -$117K
OKUR
4539
OnKure Therapeutics
OKUR
$160M
-1,344
Closed -$39K
ABLD
4540
Abacus FCF Real Assets Leaders ETF
ABLD
$96.8M
-8,064
Closed -$227K
ABOT
4541
Abacus FCF Innovation Leaders ETF
ABOT
$4.33M
-10,786
Closed -$289K
OMGA
4542
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-55,277
Closed -$344K
VINC
4543
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-2,972
Closed -$238K
TBIO
4544
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
-962
Closed -$93K
TLIS
4545
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-3,497
Closed -$74K
NEXI
4546
DELISTED
NexImmune, Inc. Common Stock
NEXI
-1,628
Closed -$171K
CSSE
4547
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-24,807
Closed -$198K
NBSE
4548
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-4,361
Closed -$164K
CCLP
4549
DELISTED
CSI Compressco LP
CCLP
-2,470,266
Closed -$3.46M
CYT
4550
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-25,005
Closed -$94K

Similar funds

Bank of New York Mellon's Q2 2022 Portfolio in Review

As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
  • Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
  • Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
  • Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
  • Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
  • Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.